Latest FENC reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Fennec Pharmaceuticals
  4. Financial Ratios
Fennec Pharmaceuticals logo
Fennec Pharmaceuticals FENC
$ 9.42 1.62%
mail-toReport an Error

Fennec Pharmaceuticals Financial Ratios 2011-2024 | FENC

Annual Financial Ratios Fennec Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -18.4 -8.3 -8.4 -9.4 -10.0 -12.5 -19.1 -9.2 -33.8 -9.9 - - -

P/S

 13.9 128.6 - - - - - - - - - - -

EPS

 -0.6 -0.9 -0.7 -0.8 -0.6 -0.5 -0.5 -0.2 -0.1 -0.2 0.2 -0.2 0.2

EV (Enterprise Value)

 321 M 203 M 131 M 143 M 116 M 103 M 108 M 22.1 M 21.8 M 21 M 1.54 M 5.02 M 174 K

EBITDA per Share

 -0.48 -0.86 -0.66 -0.738 -0.652 -0.556 -0.454 -0.232 -0.288 -0.362 - - -

EV/EBITDA

 0.8 -8.0 -8.7 -9.6 -15.6 -7.3 -6.9 -5.4 - - -

PEG

 -15.48 -0.57 -0.3 0.49 0.43 1.18 0.17 11.85 37.06 9.87 - - -

P/B

 -25.4 -76.8 9.2 5.9 10.7 5.8 5.0 7.2 40.7 35.1 - - -

P/CF

 -17.2 -10.9 -10.2 -10.9 -14.1 -15.8 -37.0 -12.0 -12.0 -12.7 - - -

ROE %

 138.06 923.08 -109.98 -62.29 -107.58 -46.39 -26.33 -78.12 -120.26 -354.98 - - -

ROA %

 -59.73 -88.03 -77.39 -57.64 -90.31 -43.08 -24.81 -70.22 -64.67 -91.74 - - -

ROCE %

 -66.13 -101.16 -82.96 -61.52 -109.55 -48.84 -25.98 -78.12 -120.26 -354.98 - - -

Current Ratio

 0.7 0.9 3.4 12.9 6.1 14.0 17.3 9.9 2.2 1.3 - - -

DSO

 89.0 183.7 - - - - - - - - - - -

DIO

 - - - - - - - - - - - - -

DPO

 894.1 6720.7 - - - - - - - - - - -

Operating Cycle

 89.0 183.7 - - - - - - - - - - -

Cash Conversion Cycle

 -805.1 -6537.0 - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Fennec Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 0.41 - -0.07 -0.21 -0.23 - -0.31 -0.19 -0.14 - -0.16 -0.15 -0.18 - -0.24 -0.21 -0.19 - -0.09 -0.24 0.14 - -0.14 -0.14 -0.09 - -0.15 -0.11 -0.06 - -0.04 -0.06 -0.04 - -0.01 -0.02 0.02 - 0.04 -0.08 -0.33 - -0.21 0.26 -0.16 - -0.03 -0.02 0.11 - -0.17 -0.01 0.23

EBITDA per Share

 - - - - - - -0.3 -0.19 -0.14 - -0.16 -0.15 -0.19 - -0.23 -0.21 -0.19 - -0.09 -0.24 -0.13 - -0.15 -0.14 -0.1 - -0.14 -0.1 -0.06 - -0.04 -0.06 -0.04 - -0.03 -0.05 -0.04 - -0.06 -0.09 -0.05 - -0.01 -0.04 -0.02 - -0.03 -49.7 -24.5 - -0.05 -0.02 -0.05

ROE %

 517.34 156.16 -132.53 -438.94 -554.29 -377.58 -399.59 -132.92 -91.49 -58.95 -80.28 -79.60 -78.31 -83.21 -98.45 -92.35 -115.52 -77.18 -90.08 -87.74 -60.05 -32.39 -41.18 -37.08 -30.91 -17.77 -49.79 -55.06 -69.37 -80.42 -146.94 -155.33 -233.59 -318.07 -574.50 -907.03 -1163.47 -1064.93 -1191.73 -963.56 -735.39 -380.41 -276.26 -45.30 185.66 312.47 -3591.70 -7600.02 -11608.34 -11712.50 -3904.17 -3904.17 -3904.17

ROA %

 -29.08 -65.56 -92.15 -108.93 -113.50 -78.47 -94.56 -84.06 -65.71 -47.33 -67.06 -70.71 -71.90 -72.06 -84.85 -77.90 -95.92 -64.79 -76.77 -75.96 -53.79 -30.08 -53.87 -65.68 -60.03 -32.25 -61.03 -49.88 -62.48 -72.28 -96.50 -95.93 -130.70 -171.05 -209.79 -289.46 -328.20 -275.21 -169.90 27.14 224.19 315.92 97.62 -226.00 -549.62 -654.93 -567.37 -261.51 44.35 262.66 87.55 87.55 87.55

ROCE %

 -20.10 -66.13 -94.87 -116.87 -127.05 -89.55 -106.94 -95.59 -69.99 -51.51 -71.66 -74.43 -76.72 -82.15 -97.84 -93.37 -117.23 -78.79 -92.15 -89.82 -61.80 -34.27 -42.44 -37.25 -30.27 -16.58 -32.38 -40.01 -54.28 -48.32 -110.00 -155.88 -236.26 -244.34 -345.32 -384.62 -436.15 -340.29 -336.79 -232.30 -16.88 104.12 116.83 126.04 87.54 50.35 837.02 1610.98 2062.43 2114.17 786.67 476.67 850.83

Current Ratio

 1.1 0.7 0.6 0.7 0.8 0.9 1.1 2.2 2.9 3.4 3.7 4.8 - 13.4 13.4 13.4 - 6.2 - - - 14.0 11.1 27.1 19.6 17.3 6.0 17.3 17.3 9.9 9.9 9.9 9.9 2.2 2.2 2.2 2.2 1.4 1.4 1.4 1.4 0.6 0.6 0.6 0.6 0.3 0.3 0.3 0.3 1.0 1.0 1.0 1.0

DSO

 34.3 - 48.8 - 87.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - 819.6 1834.9 2563.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 34.3 - 48.8 - 87.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 34.3 - -770.8 -1834.9 -2475.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency